It has been confirmed that suppression of the Wnt/β‐catenin signaling could significantly alleviate bleomycin‐induced pulmonary fibrosis accompanied by reducing expression of TGF‐β1 and FGF2 in vitro and in vivo [38]. The gene discussed is FGF2; the disease is pulmonary fibrosis.